382 related articles for article (PubMed ID: 4025166)
1. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
Reiter MJ; Easley AR; Mann DE
Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
Kim SG; Felder SD; Waspe LE; Fisher JD
Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
[TBL] [Abstract][Full Text] [Related]
6. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
[TBL] [Abstract][Full Text] [Related]
7. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
[TBL] [Abstract][Full Text] [Related]
8. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
DiMarco JP; Garan H; Ruskin JN
Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
[TBL] [Abstract][Full Text] [Related]
9. Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery disease.
Kudenchuk PJ; Kron J; Walance CG; Cutler JE; Griffith KK; McAnulty JH
Am J Cardiol; 1990 Sep; 66(7):725-30. PubMed ID: 2399890
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
[TBL] [Abstract][Full Text] [Related]
11. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
[TBL] [Abstract][Full Text] [Related]
12. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Toivonen L; Kadish A; Morady F
Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
[TBL] [Abstract][Full Text] [Related]
13. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
Waspe LE; Waxman HL; Buxton AE; Josephson ME
Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
[TBL] [Abstract][Full Text] [Related]
15. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
Nademanee K; Singh BN
Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735
[TBL] [Abstract][Full Text] [Related]
16. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents.
Hook BG; Rosenthal ME; Marchlinski FE; Buxton AE; Josephson ME
Pacing Clin Electrophysiol; 1992 Mar; 15(3):324-33. PubMed ID: 1372727
[TBL] [Abstract][Full Text] [Related]
17. Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia.
Mendes L; Podrid PJ; Fuchs T; Franklin S
J Am Coll Cardiol; 1991 May; 17(6):1396-402. PubMed ID: 2016457
[TBL] [Abstract][Full Text] [Related]
18. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Waxman HL; Buxton AE; Sadowski LM; Josephson ME
Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
[TBL] [Abstract][Full Text] [Related]
19. Serial electropharmacologic studies in patients with ischemic heart disease and sustained ventricular tachyarrhythmias: when is drug testing sufficient?
Kudenchuk PJ; Halperin B; Kron J; Walance CG; Griffith KK; McAnulty JH
Am J Cardiol; 1993 Dec; 72(18):1400-5. PubMed ID: 8256734
[TBL] [Abstract][Full Text] [Related]
20. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
Breithardt G; Seipel L; Abendroth RR; Loogen F
Eur Heart J; 1980 Feb; 1(1):11-24. PubMed ID: 7026245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
